Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-014426
Filing Date
2021-06-09
Accepted
2021-06-09 16:25:01
Documents
1
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3747
  Complete submission text file 0001437749-21-014426.txt   5103
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2575 W. BELLFORT SUITE 333 HOUSTON TX 77054
Business Address
George Robert E. (Reporting) CIK: 0001674701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 211005376